 Date: 2016-07-21 09:25:25Biotechnology Biology Medicine Recombinant proteins Specialty drugs Biosimilar Drugs Biopharmaceutical Trastuzumab Mylan Pegfilgrastim Filgrastim | |  Press Release Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency BENGALURU, India and HERTFORDSHIRE, England/PITTSBURGH, USA, July 21, 20
Add to Reading ListSource URL: www.biocon.comDownload Document from Source Website File Size: 437,77 KBShare Document on Facebook
|
